SafeScript NSW's new approval management functionality

Thursday, 16 November, 2023

SafeScript NSW's new approval management functionality

SafeScript NSW’s new approval management functionality will allow prescribers — medical, nurse and dental practitioners — to apply online for approval to prescribe or supply certain Schedule 8 medicines, according to the Primary Health Network.

It will also allow them to: monitor application progress; in some cases, be issued approvals in real time; view patient approval (previously referred to as an authority) history; have visibility of the number of active approvals held; and see all approvals held within their organisations, noted the PHN in a statement.

The new functionality will enable pharmacists to view a summary of opioid treatment program (OTP) approval information in the system, including: the approval number (previously referred to as authority); start and end dates; OTP dosing points; prescriber, patient, drug and maximum dose information.

Justice Health and public OTP clinic support employees (such as registered nurses and administration support employees) who are involved in the OTP process will be able to access the system through an invitation from a prescriber, said the PHN.

The enhanced functionality is aimed at improving efficiency and providing greater compliance and support. Prescribers will also start receiving notifications to their nominated email regarding the progress on any of the applications that have been submitted to the Pharmaceutical Regulatory Unit (PRU) for all approval types regardless of method of submission.

Image credit: Anthony Eddy

Related News

Most people with psychosis known to health services: study

Three out of four people who committed serious violent offences in NSW and were found not guilty...

Call to improve prevention and management of chronic conditions

The Australian Medical Association is urging action on the prevention and management of chronic...

Insomnia medication for alcohol use disorder?

Researchers are recommending full-scale human trials after an insomnia drug helped a man withdraw...

  • All content Copyright © 2024 Westwick-Farrow Pty Ltd